ArticleMolecular cancer therapeutics2024

4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Marissa L Calbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.